Topic: Arthritis

Aratana scores third FDA approval of the year

Shares of Aratana Therapeutics rose more than 3% to $9.75 in after-hours trading on August 15, when the company announced that the FDA approved Nocita (bupivacaine), its long-acting injectable drug to relieve pain in dogs after ligament surgery.